Chemistry: analytical and immunological testing – Composition for standardization – calibration – simulation,... – Protein or peptide standard or control
Reexamination Certificate
2007-11-06
2007-11-06
Gitomer, Ralph (Department: 1657)
Chemistry: analytical and immunological testing
Composition for standardization, calibration, simulation,...
Protein or peptide standard or control
C435S967000, C436S008000
Reexamination Certificate
active
10721031
ABSTRACT:
The present invention relates to methods for making stable compositions, such as, but not limited to, test samples, that can be used in ligand-binding assays.
REFERENCES:
patent: 4607023 (1986-08-01), Thibualt et al.
patent: 5352587 (1994-10-01), Chang et al.
patent: 5358691 (1994-10-01), Clark et al.
patent: 5444041 (1995-08-01), Owen et al.
patent: 5514670 (1996-05-01), Friedman et al.
patent: 5541116 (1996-07-01), Bergmann
patent: 5707648 (1998-01-01), Yiv
patent: 6376207 (2002-04-01), Mischak et al.
patent: 6407211 (2002-06-01), Burnett et al.
patent: 6525102 (2003-02-01), Chen et al.
patent: 2005/0136542 (2005-06-01), Todtleben et al.
patent: 1030177 (2000-08-01), None
patent: 1378242 (2004-01-01), None
patent: 05170664 (1993-10-01), None
patent: WO96/27661 (1996-09-01), None
Motwani, et al., “Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infraction”. The Lancet, 341: 1109-1113, (1997).
Cataliotti, et al., “Circulating Natriuretic Peptide Concentrations in Patients With End-Stage Renal Disease: Role of Brain Natriuretic Peptide as a Biomaker for Ventricular Remodeling”. Mayo Foundation for Medical Education and Research, 76: 1111-1119, (2001).
Mukoyama, et al., “Brain Natriuetic Peptide as a Novel Cardiac Hormone in Humans.” Journal Clinical Investigation, 87: 11402-11412, (1991).
Yandle, T.G., “Minisymposium: The Natriuretic Peptide Hormones; Biochemistry of natriuretic peptides”, Journal of Internal Medicine. 235: 561-576, (1994).
Murdoch, et al., “Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice”. Heart 1997; 78:594-597.
Davidson et al., “Brain natriuretic peptide”. Journal of Hypertension, 1994; 12:329-336.
Yoshibayashi, et al., “Increased Plasma Levels of Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy”. The New England Journal of Medicine, 1993; vol. 32, No. 6, pp. 433-435.
Shimizu, et al., “Molecular forms of human brain natriuretic peptide in plasma”. Clinica Chimica Acta, 2002; 129-135.
Tsuji Tetsuo et al.,Clinical Chemistry“Stabilization of human brain natriuretic peptide in blood samples” 40(4): 672-673 (1994).
Gutkowska J et al.,Biochemical and Biophysical Research Comm“Atrial natriuretic factor in human plasma” 139(1): 287-295 (Aug. 1986).
Kelly P M et al.,Clinical Chemistry“A novel assay for the measurement of plasma B-type natriuretic peptide by an AxSYN® microparticle based immunoassay with use of stable liquid calibrators” 48(6): A94 (Jun. 2002).
Diagnostic Automation/Cortez Diagnostics, Inc, Nt-proBNP ELISA Quantitative Determination of Nt-proBNP in Biological Fluids (Cat. No. 2852-7), pp. 1-8 (1997).
Alpco Diagnostics, Nt-proBNP EIA (Cat. No. 04-B1-20852), pp. 1-5 (Oct. 12, 2004).
Daghfal David J.
Friese Judith A.
Lipowsky Cherie A.
Parsons Robert G.
Weigand Ray A.
Abbott Laboratories
Bartnicki Audrey L.
Gitomer Ralph
LandOfFree
Stable compositions for measuring human natriuretic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable compositions for measuring human natriuretic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable compositions for measuring human natriuretic peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3830194